ES2998534T3 - Phenyl carbamate compounds for use in preventing or treating pediatric epilesy - Google Patents
Phenyl carbamate compounds for use in preventing or treating pediatric epilesy Download PDFInfo
- Publication number
- ES2998534T3 ES2998534T3 ES14762362T ES14762362T ES2998534T3 ES 2998534 T3 ES2998534 T3 ES 2998534T3 ES 14762362 T ES14762362 T ES 14762362T ES 14762362 T ES14762362 T ES 14762362T ES 2998534 T3 ES2998534 T3 ES 2998534T3
- Authority
- ES
- Spain
- Prior art keywords
- chlorophenyl
- hydroxypropyl
- carbamate
- preparation example
- epilepsy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
- A61K31/025—Halogenated hydrocarbons carbocyclic
- A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/055—Phenols the aromatic ring being substituted by halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361776926P | 2013-03-12 | 2013-03-12 | |
| PCT/KR2014/001903 WO2014142477A1 (en) | 2013-03-12 | 2014-03-07 | Phenyl carbamate compounds for use in preventing or treating pediatric epilesy and epilesy-related syndromes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2998534T3 true ES2998534T3 (en) | 2025-02-20 |
Family
ID=51530016
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14762362T Active ES2998534T3 (en) | 2013-03-12 | 2014-03-07 | Phenyl carbamate compounds for use in preventing or treating pediatric epilesy |
| ES14764907T Active ES3046835T3 (en) | 2013-03-12 | 2014-03-11 | Phenyl carbamate compounds for use in preventing or treating epilepsy or epilepsy-related syndrome |
| ES14764227T Active ES2881850T3 (es) | 2013-03-12 | 2014-03-11 | Compuestos de carmato de fenil alquilo para su uso en la prevención o tratamiento de la epilepsia o síndrome relacionado con la epilepsia |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14764907T Active ES3046835T3 (en) | 2013-03-12 | 2014-03-11 | Phenyl carbamate compounds for use in preventing or treating epilepsy or epilepsy-related syndrome |
| ES14764227T Active ES2881850T3 (es) | 2013-03-12 | 2014-03-11 | Compuestos de carmato de fenil alquilo para su uso en la prevención o tratamiento de la epilepsia o síndrome relacionado con la epilepsia |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US9504668B2 (enExample) |
| EP (4) | EP2968210B1 (enExample) |
| JP (5) | JP6062077B2 (enExample) |
| KR (5) | KR101717872B1 (enExample) |
| CN (6) | CN109939092B (enExample) |
| ES (3) | ES2998534T3 (enExample) |
| WO (4) | WO2014142477A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109939092B (zh) * | 2013-03-12 | 2022-03-22 | 比皮艾思药物研发有限公司 | 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物 |
| CN110478343A (zh) | 2013-03-12 | 2019-11-22 | 比皮艾思药物研发有限公司 | 氨基甲酸苯酯化合物和包含该化合物的用于预防或治疗神经性毒气引起的疾病的组合物 |
| WO2017150903A1 (en) * | 2016-02-29 | 2017-09-08 | Bio-Pharm Solutions Co., Ltd. | Sulfamate derivative compounds, processes for preparing them and their uses |
| KR102635941B1 (ko) * | 2016-12-14 | 2024-02-13 | 에스케이바이오팜 주식회사 | 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
| CN109920550A (zh) * | 2018-12-25 | 2019-06-21 | 天津大学 | 一种基于dMRI研究青少年肌阵挛性癫痫的方法 |
| CA3191072A1 (en) | 2020-08-31 | 2022-03-03 | Bio-Pharm Solutions Co., Ltd. | Phenyl alkyl carbamate compounds for use in preventing or treating neurodegenerative disease |
| CN116234798A (zh) | 2020-09-10 | 2023-06-06 | 生物药品解决方案有限公司 | 用于治疗或缓解精神疾病的氨基磺酸酯衍生物化合物 |
| US12054449B2 (en) | 2021-08-05 | 2024-08-06 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate crystalline form and method for manufacturing the same |
| CN119552104B (zh) * | 2024-12-03 | 2025-07-15 | 西安瑞谱源生物技术有限公司 | 一种氘代维生素a的制备方法 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3313696A (en) | 1962-06-26 | 1967-04-11 | Armour Pharmacentical Company | Carbamate sedative compositions and method of use |
| US3313699A (en) | 1962-06-26 | 1967-04-11 | Armour Pharma | Compositions for and method of treating the central nervous system |
| US3313697A (en) * | 1962-06-26 | 1967-04-11 | Armour Pharma | Carbamate compositions for and methods of treating the central nervous system |
| US3313700A (en) * | 1962-07-18 | 1967-04-11 | Armour Pharmacentical Company | Method of treating the central nervous system with substituted phenethyl carbamates and compositions therefor |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| FR5671M (enExample) * | 1965-04-23 | 1968-01-02 | ||
| JPS61271992A (ja) | 1985-05-28 | 1986-12-02 | Central Glass Co Ltd | 光学活性ジオ−ルの製造方法 |
| US5258397A (en) | 1988-11-30 | 1993-11-02 | Novapharme | 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions |
| FR2686084B1 (fr) * | 1992-01-10 | 1995-12-22 | Bioprojet Soc Civ | Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques. |
| KR100197901B1 (ko) * | 1994-02-21 | 1999-06-15 | 남창우 | 페닐-1,2-에탄디올 광학이성체의 단일 카바메이트 |
| US20100210590A1 (en) * | 1995-09-27 | 2010-08-19 | Northwestern University | Compositions and treatments for seizure-related disorders |
| US20010034365A1 (en) * | 1996-01-16 | 2001-10-25 | Choi Yong Moon | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| US5698588A (en) | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| UA65607C2 (uk) * | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
| AU4215499A (en) | 1998-05-28 | 2002-07-08 | Codon Pharmaceuticals, Inc. | Treatment of neurodegenerative diseases |
| TW544311B (en) * | 1998-08-06 | 2003-08-01 | Daiichi Seiyaku Co | Therapeutic or preventive agent for intractable epilepsies |
| AU2002242296B2 (en) | 2001-02-27 | 2006-06-29 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating psychotic disorders |
| PT1383489E (pt) | 2001-02-27 | 2007-06-21 | Ortho Mcneil Pharm Inc | Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos |
| US7078436B2 (en) * | 2001-02-27 | 2006-07-18 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating anxiety disorders |
| ATE369130T1 (de) * | 2001-02-27 | 2007-08-15 | Ortho Mcneil Pharm Inc | Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen |
| MXPA03007721A (es) | 2001-02-27 | 2004-11-12 | Johnson & Johnson | Compuesto de carbamato para su uso en el tratamiento del dolor. |
| US7199135B2 (en) * | 2001-07-05 | 2007-04-03 | H. Lundbeck A/S | Substituted alkyl amido piperidines |
| AU2003242124A1 (en) * | 2002-06-11 | 2003-12-22 | Institute Of Medicinal Molecular Design, Inc. | Medicament for treatment of neurodegenerative diseases |
| ATE464044T1 (de) | 2004-09-16 | 2010-04-15 | Janssen Pharmaceutica Nv | Verwendung von 2-phenyl-1,2-ethanediol- (di)carbamaten zur behandlung von epileptogenese |
| EP1717235A3 (en) * | 2005-04-29 | 2007-02-28 | Bioprojet | Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands |
| US20070021501A1 (en) * | 2005-07-12 | 2007-01-25 | Twyman Roy E | Methods of treating epileptogenesis |
| SA07280403B1 (ar) | 2006-07-28 | 2010-12-01 | إيساي أر أند دي منجمنت كو. ليمتد | ملح رباعي لمركب سيناميد |
| AU2007313018A1 (en) * | 2006-10-13 | 2008-04-24 | Janssen Pharmaceutica N.V. | Phenylalkyl carbamate compositions |
| MX2009003926A (es) | 2006-10-13 | 2009-06-26 | Janssen Pharmaceutica Nv | Composiciones de fenilalquilamino-carbamato. |
| US20080103198A1 (en) | 2006-10-27 | 2008-05-01 | Haas Magali | Methods for treatment of cochlear and vestibular disorders |
| EP2081648A2 (en) | 2006-10-30 | 2009-07-29 | Janssen Pharmaceutica, N.V. | Carbamate compounds for use in treating depression |
| US7863499B2 (en) | 2007-02-08 | 2011-01-04 | Albert Einstein College Of Medicine Of Yeshiva University | Model of infantile spasm syndrome |
| CA2683398A1 (en) | 2007-04-10 | 2008-10-16 | Sgx Pharmaceuticals, Inc. | Fused ring heterocycle kinase modulators |
| WO2010022300A1 (en) | 2008-08-21 | 2010-02-25 | Forest Laboratories Holdings Limited | Methods for treating neuropathic pain |
| BRPI0925343A2 (pt) | 2008-10-02 | 2015-07-28 | Taisho Pharmaceutical Co Ltd | Composto, composição farmacêutica, e, droga profilática ou terapêutica |
| CN102448937A (zh) | 2009-05-29 | 2012-05-09 | 拉夸里亚创药株式会社 | 作为钙或钠通道阻滞剂的芳基取代羧酰胺衍生物 |
| EP2461807A1 (en) * | 2009-08-05 | 2012-06-13 | Convergence Pharmaceuticals Limited | Co-therapy for the treatment of epilepsy and related disorders |
| ES2711619T3 (es) * | 2010-07-02 | 2019-05-06 | Bio Pharm Solutions Co Ltd | Compuesto carbamato de fenilo y relajante muscular que contiene dicho compuesto |
| US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
| CA2815460C (en) * | 2011-01-13 | 2017-04-18 | Bio-Pharm Solutions Co., Ltd. | Process for preparation of phenyl carbamate derivatives |
| WO2013100566A1 (en) | 2011-12-27 | 2013-07-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same |
| CN109939092B (zh) | 2013-03-12 | 2022-03-22 | 比皮艾思药物研发有限公司 | 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物 |
| CN110478343A (zh) | 2013-03-12 | 2019-11-22 | 比皮艾思药物研发有限公司 | 氨基甲酸苯酯化合物和包含该化合物的用于预防或治疗神经性毒气引起的疾病的组合物 |
-
2014
- 2014-03-07 CN CN201910335069.2A patent/CN109939092B/zh active Active
- 2014-03-07 CN CN201480015460.XA patent/CN105228604A/zh active Pending
- 2014-03-07 JP JP2015562906A patent/JP6062077B2/ja active Active
- 2014-03-07 KR KR1020157026389A patent/KR101717872B1/ko active Active
- 2014-03-07 EP EP14762362.3A patent/EP2968210B1/en active Active
- 2014-03-07 WO PCT/KR2014/001903 patent/WO2014142477A1/en not_active Ceased
- 2014-03-07 ES ES14762362T patent/ES2998534T3/es active Active
- 2014-03-11 ES ES14764907T patent/ES3046835T3/es active Active
- 2014-03-11 WO PCT/KR2014/002007 patent/WO2014142520A1/en not_active Ceased
- 2014-03-11 CN CN201480015456.3A patent/CN105209027A/zh active Pending
- 2014-03-11 ES ES14764227T patent/ES2881850T3/es active Active
- 2014-03-11 EP EP14765077.4A patent/EP2968213A4/en not_active Withdrawn
- 2014-03-11 KR KR1020157026378A patent/KR20150120518A/ko not_active Ceased
- 2014-03-11 US US14/774,287 patent/US9504668B2/en active Active
- 2014-03-11 WO PCT/KR2014/002005 patent/WO2014142518A1/en not_active Ceased
- 2014-03-11 JP JP2015562915A patent/JP6062078B2/ja active Active
- 2014-03-11 US US14/204,298 patent/US20140275243A1/en not_active Abandoned
- 2014-03-11 EP EP14764907.3A patent/EP2968212B1/en active Active
- 2014-03-11 JP JP2015562913A patent/JP6200526B2/ja active Active
- 2014-03-11 CN CN202010408166.2A patent/CN111419830B/zh active Active
- 2014-03-11 US US14/775,189 patent/US9682059B2/en active Active
- 2014-03-11 CN CN201480015516.1A patent/CN105188690B/zh active Active
- 2014-03-11 JP JP2015562914A patent/JP6215971B2/ja active Active
- 2014-03-11 KR KR1020157026369A patent/KR101739676B1/ko active Active
- 2014-03-11 KR KR1020177013680A patent/KR101992035B1/ko active Active
- 2014-03-11 WO PCT/KR2014/002006 patent/WO2014142519A1/en not_active Ceased
- 2014-03-11 KR KR1020157026390A patent/KR101717873B1/ko active Active
- 2014-03-11 EP EP14764227.6A patent/EP2968211B1/en active Active
- 2014-03-11 CN CN201480015472.2A patent/CN105188689B/zh active Active
- 2014-03-11 US US14/775,092 patent/US9872847B2/en active Active
-
2016
- 2016-06-22 US US15/190,123 patent/US9956197B2/en active Active
-
2017
- 2017-07-07 JP JP2017133937A patent/JP2017206546A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2998534T3 (en) | Phenyl carbamate compounds for use in preventing or treating pediatric epilesy | |
| ES2716832T3 (es) | Compuestos carbamatos de fenilo para su uso en el alivio o el tratamiento del dolor y el dolor neuropático | |
| US9907776B2 (en) | Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same | |
| US8440715B2 (en) | Treatment of sleep-wake disorders | |
| EP2590936B1 (en) | Phenylcarbamate compound and muscle relaxant containing the same | |
| EP2521731B1 (en) | Compounds with both analgesic and anti-hyperalgesic efficacy | |
| US20180214436A1 (en) | Phacetoperane for treating of attention deficit hyperactivity disorder | |
| EP4400494A1 (en) | Novel compound and use thereof for treating emotional behavioral disorders |